Sanjay Bandyopadhyay

6PUBLICATIONS
12CO-AUTHORS
Nutritional epidemiologyMetabolic medicineNaturopathyMedical biochemistry - lipidsAgrochemicals and biocides (incl. application)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
Real-World Observational Clinical Study Assessing the Effectiveness and Safety of Vonoprazan-Based Dual Therapy Versus Proton Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication.

|Apr 29, 2026
The Mitochondrial-Autophagy Axis in MASLD: Mechanisms, Crosstalk, and Therapeutic Targets.

|Apr 20, 2026
Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis.

|Dec 10, 2025
Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD, and Stage 3 chronic kidney disease: A 12-month observational study.

Gaurab Bhaduri, Shambo S Samajdar, Sanjay Bandyopadhyay

|Nov 24, 2025
Efficacy of Vonoprazan in Nonsteroidal Anti-Inflammatory Drug-Induced Ulcer in Terms of Ulcer Recurrence and Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

Sanjay Bandyopadhyay, Shambo Samrat Samajdar, Saibal Das

|Oct 02, 2024
An insight into the updated pharmacotherapy of metabolic-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatohepatitis (MASH) in lean individuals: a review.

Sanjay Bandyopadhyay, Shambo Samrat Samajdar, Sirshendu Chaudhuri

Pageof 1

Frequent Collaborators

2 joint publications

Saibal Das

2 joint publications

Gaurab Bhaduri

1 joint publications

Shambo Samrat Samajdar

1 joint publications

Sirshendu Chaudhuri